Tenax Therapeutics, Inc. (TENX)
1.78
-0.07
(-3.78%)
USD |
NASDAQ |
Sep 03, 16:00
1.81
+0.03
(+1.69%)
After-Hours: 20:00
Tenax Therapeutics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0016M |
| March 31, 2023 | 0.0012M |
| December 31, 2022 | 0.004M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0063M |
| December 31, 2021 | -0.0017M |
| September 30, 2021 | 0.5115M |
| June 30, 2021 | -0.0203M |
| March 31, 2021 | -0.037M |
| December 31, 2020 | 0.0035M |
| September 30, 2020 | 0.0027M |
| June 30, 2020 | 0.0202M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0063M |
| December 31, 2019 | -0.0167M |
| September 30, 2019 | 0.0241M |
| June 30, 2019 | -0.0002M |
| March 31, 2019 | -0.0088M |
| December 31, 2018 | 1.311M |
| September 30, 2018 | 1.00M |
| June 30, 2018 | 2.097M |
| March 31, 2018 | 2.947M |
| December 31, 2017 | 1.123M |
| September 30, 2017 | 0.7561M |
| June 30, 2017 | 0.8005M |
| March 31, 2017 | 1.070M |
| December 31, 2016 | 12.38M |
| September 30, 2016 | 3.075M |
| June 30, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | -0.3809M |
| April 30, 2015 | -0.3105M |
| January 31, 2015 | -1.365M |
| October 31, 2014 | -4.673M |
| July 31, 2014 | -34.58M |
| April 30, 2014 | -0.034M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 17.77M |
| Absci Corp. | 24.07M |
| Celularity, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.15M |
| Cash from Financing (Quarterly) | 13.37M |
| Free Cash Flow | -46.03M |
| Free Cash Flow Per Share (Quarterly) | -0.2782 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.15M |
| Free Cash Flow Yield | -58.52% |